Related Experiment Video
Updated: Jun 19, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
A mildly altered vascular homeostasis in early stage of CKD
Narisa Futrakul1, Prasit Futrakul
1King Chulalongkorn Memorial Hospital, Bangkok, Thailand. fmednft@md.chula.ac.th
Insights
Vascular repair mechanisms are functional in early-stage chronic kidney disease (CKD). Early therapeutic interventions in CKD patients can improve renal perfusion and function, highlighting the importance of timely treatment.
Area of Science:
- Nephrology
- Vascular Biology
- Regenerative Medicine
Background:
- Chronic kidney disease (CKD) progression to end-stage renal disease (ESRD) poses a significant public health challenge.
- Current therapeutic strategies often fail due to initiation at late stages of CKD.
Purpose of the Study:
- To investigate the vascular repair mechanisms in early-stage CKD patients with mildly impaired renal function.
- To analyze key angiogenic factors: vascular endothelial growth factor (VEGF), angiopoietin-1, and fms-like tyrosine kinase-1 (FLT-1/VEGFR1).
- To assess antiangiogenic factors: angiopoietin-2 and kinase insert domain receptor (KDR/VEGFR2).
Main Methods:
- Analysis of angiogenic factors (VEGF, angiopoietin-1, FLT-1/VEGFR1) in CKD patients.
- Assessment of antiangiogenic factors (angiopoietin-2, KDR/VEGFR2) in the same patient cohort.
- Correlation of factor levels with renal function and vascular repair markers.
Main Results:
- A mild decrease in the angiogenic factor angiopoietin-1 was observed.
- Elevated levels of the antiangiogenic factor angiopoietin-2 were noted.
- VEGF, FLT-1/VEGFR1, and KDR/VEGFR2 levels remained within normal limits, suggesting preserved vascular repair capacity.
Conclusions:
- Vascular repair mechanisms are functional in the early stages of CKD.
- Early therapeutic interventions targeting renal regeneration can enhance renal perfusion and function, particularly in normoalbuminuric type 2 diabetic nephropathy.
- A paradigm shift towards early-stage CKD treatment is recommended to improve patient outcomes.
Background:
A continuous increase in number of CKD patients entering ESRD is a growing public health threat, which reflects the present therapeutic failure usually initiating at the late stage of CKD.
Objective:
To study the mechanism of vascular repair in CKD patients associated with mildly impaired renal function, which included angiogenic factors such as VEFG, angiopoietin-1, and flt-1 (VEGFR1); and antiangiogenic factors such as angiopoietin-2 and KDR (VEGFR2).
Results:
A mild defect in angiogenic factor-namely, angiopoietin-1-was observed, whereas VEGF and flt-1 (VEGFR1) were within normal limit. Also, antiangiogenic factor-namely, angiopoietin-2-was mildly elevated, whereas KDR (VEGFR2) remained within normal limit.
Conclusion:
The mechanism of vascular repair appears to be adequately functional in the early stage of CKD. Therapeutic intervention at this stage can improve renal perfusion and restore renal function as indicated in normoalbuminuric, type 2 diabetic nephropathy. The authors encourage changing the conceptual view of treatment under common treatment at late stage of CKD to treatment at early stage of CKD under an environment favorable for renal regeneration.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology

